Skip to main content
main-content

Editor's pick

06-06-2020 | EULAR 2020 | Conference coverage | Video

Researcher comment: COVID-19 risk factors in RMD patients

Pedro Machado discusses data from the COVID-19 Global Rheumatology Alliance registry on the risk factors for COVID-19 hospitalization in patients with rheumatic and musculoskeletal diseases (9:30).

06-06-2020 | EULAR 2020 | Conference coverage | Video

Researcher comment: SELECT-PsA-2

Philip Mease describes the findings from the SELECT-PsA-2 trial of upadacitinib in patients with psoriatic arthritis and an inadequate response to biologic DMARDs (6.18).

05-06-2020 | EULAR 2020 | Conference coverage | Video

Researcher comment: The BLISS-LN trial

This BLISS-LN trial demonstrated the potential of belimumab as an add-on therapy for patients with lupus nephritis; lead investigator Richard Furie discusses why these findings are important for this patient population (8:28).

The latest coverage from the EULAR 2020 E-Congress

Including news and expert interviews on the SELECT-CHOICE, EXCEED, JAK-pot, and BLISS-LN studies.

Latest from across the site

06-06-2020 | EULAR 2020 | Conference coverage | News

Anakinra ‘an additional option’ to treat flares in difficult-to-treat gout

Phase 2 study anaGO findings presented in a poster at the EULAR 2020 E-congress reveal that patients with difficult-to-treat gout who receive the interleukin-1 receptor antagonist anakinra report comparable levels of pain reduction to those given triamcinolone.

06-06-2020 | EULAR 2020 | Conference coverage | Video

Expert commentary: VTE in patients with RA

John Isaacs comments on two studies on venous thromboembolism in patients with rheumatoid arthritis, highlighting the robustness of the findings and what they mean for patient management (5:47).

06-06-2020 | EULAR 2020 | Conference coverage | News

No benefit of hydroxychloroquine for inflammatory, erosive hand osteoarthritis

The OA TREAT investigators have demonstrated that hydroxychloroquine does not improve pain, function, or radiographic progression in patients with inflammatory and erosive hand osteoarthritis.

06-06-2020 | EULAR 2020 | Conference coverage | News

Etanercept linked to elevated risk for anterior uveitis in patients with SpA

Etanercept is associated with a higher risk for anterior uveitis than adalimumab among patients with spondyloarthritis, suggests a Swedish registry study.

06-06-2020 | EULAR 2020 | Conference coverage | Video

Researcher comment: COVID-19 risk factors in RMD patients

Pedro Machado discusses data from the COVID-19 Global Rheumatology Alliance registry on the risk factors for COVID-19 hospitalization in patients with rheumatic and musculoskeletal diseases (9:30).

06-06-2020 | EULAR 2020 | Conference coverage | Video

Researcher comment: SELECT-PsA-2

Philip Mease describes the findings from the SELECT-PsA-2 trial of upadacitinib in patients with psoriatic arthritis and an inadequate response to biologic DMARDs (6.18).

Latest from us on Twitter

Trending this week

Meet our Editorial Board

New Content Item Meet our Advisory Board

Image Credits